Back to Search Results


Hematoma after Delivery

Author: Theodore Barrett, MD

Registered users can also download a PDF or listen to a podcast of this Pearl.
Log in now, or create a free account to access bonus Pearls features.

Editor: Roger Smith, MD


Puerperal hematomas can occur after spontaneous or operative vaginal delivery. Frequently cited risk factors include the use of vacuum or forceps, nulliparity, preeclampsia, coagulation disorders, multiple gestation, and improper surgical repair of an episiotomy. Trauma to these vessels may also occur because of a compound presentation, rapid descent, and lacerations from an operative vaginal delivery including unrecognized subcutaneous tissue caught in the vacuum cup. The patient usually complains of pain or an inability to void, depending on the size and location of the hematoma.

The mechanism of puerperal hematoma formation in the anterior and posterior triangles involves rupture of branches of the internal pudendal and inferior rectal arteries, respectively. Rupture of descending branches of the uterine artery can cause paravaginal hematoma formation. Rupture of any vessel of the perineal venous plexus may also result in a hematoma. Vessel rupture can occur without laceration of the superficial tissue. Since the subcutaneous tissue in the vagina is quite pliable, hematomas can achieve massive dimensions.

The diagnosis is generally obvious, but should prompt a thorough vaginal examination to determine the extent of the lesion and the presence of any possible associated lacerations. The hematoma may be located at the vulva, may track into the vagina, or may expand into the retroperitoneal space or abdominal cavity. In these scenarios, blood loss can be concealed leading to hemodynamic instability if not recognized and addressed promptly. Rectal pain with minimal vulvar visualization of a hematoma may be a sign of retroperitoneal bleeding.  Clot formation can cause pressure necrosis and skin rupture resulting in life threatening hemorrhage. Imaging studies can help define the dimensions of the hematoma in situations where physical examination is insufficient. Vital signs and symptoms of hypovolemia should be monitored more frequently in situations where concealed bleeding is suspected. Failure to recognize on-going retroperitoneal bleeding can be fatal.

Successful management depends on prompt recognition. In some situations, the clot may provide sufficient pressure to tamponade bleeding vessels. If the hematoma is not acutely expanding, conservative measures such as ice packs, observation, pain management and bladder drainage may be all that is necessary. In situations where there is an acutely expanding hematoma or a concealed hemorrhage is suspected, more aggressive management is required. The patient’s fluid input and output should be closely monitored, intravenous access should be maintained in case fluid resuscitation or blood transfusion is required, and the other members of the healthcare team (e.g. Operating Room and Anesthesia personnel) should be notified. Surgical management includes prophylactic antibiotic administration, evacuation of the hematoma, identification and ligation of the bleeding vessels, and repair of the cavity defect left from the evacuated hematoma. Artery embolization has been used successfully to manage on-going hemorrhage in situations where bleeding is not controlled with conventional surgical techniques.

Further Reading:

Cunningham FG, Leveno KJ, Bloom S, et al., 25th eds. Obstetrical Hemorrhage, Williams Obstetrics. McGraw-Hill, New York, 2018. pp 705-802

Initial Approval: December 2012; Revised September 2018, Previously titled “Hematoma After Delivery” – renamed to current title September 2018


********** Notice Regarding Use ************

The Foundation for Exxcellence in Women’s Health, Inc (“Foundation”) is committed to accuracy and will review and validate all Pearls on an ongoing basis to reflect current practice.

This document is designed to aid practitioners in providing appropriate obstetric and gynecologic care. Recommendations are derived from major society guidelines and high quality evidence when available, supplemented by the opinion of the author and editorial board when necessary. It should not be construed as dictating an exclusive course of treatment or procedure to be followed.

Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. The Foundation reviews the articles regularly; however, its publications may not reflect the most recent evidence. While we make every effort to present accurate and reliable information, this publication is provided “as is” without any warranty of accuracy, reliability, or otherwise, either express or implied. The Foundation does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Neither the Foundation, the ABOG, SASGOG nor their respective officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented.

Copyright 2018 The Foundation for Exxcellence in Women's Health, Inc. All rights reserved.  No re-print, duplication or posting allowed without prior written consent.

Back to Search Results